E Péquignot

487 total citations
19 papers, 393 citations indexed

About

E Péquignot is a scholar working on Oncology, Physiology and Genetics. According to data from OpenAlex, E Péquignot has authored 19 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Physiology and 4 papers in Genetics. Recurrent topics in E Péquignot's work include Adipose Tissue and Metabolism (4 papers), Genetic factors in colorectal cancer (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). E Péquignot is often cited by papers focused on Adipose Tissue and Metabolism (4 papers), Genetic factors in colorectal cancer (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). E Péquignot collaborates with scholars based in United States, France and South Korea. E Péquignot's co-authors include P. de Gasquet, Walter W. Hauck, Howard Greenberg, Maria Luisa Veronese, Lisa Gillen, Joanne Burke, Scott A. Waldman, Richard K. Valicenti, A. Gabriella Wernicke and Fausto Foresti and has published in prestigious journals such as Journal of Hepatology, International Journal of Radiation Oncology*Biology*Physics and Clinical Pharmacology & Therapeutics.

In The Last Decade

E Péquignot

18 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Péquignot United States 10 85 76 69 66 58 19 393
Masahiro Nishizumi Japan 13 83 1.0× 59 0.8× 96 1.4× 78 1.2× 39 0.7× 37 687
Ibrahim M. Yousef Canada 14 67 0.8× 55 0.7× 97 1.4× 143 2.2× 53 0.9× 31 526
Jin‐Ying Lu Taiwan 12 121 1.4× 42 0.6× 97 1.4× 44 0.7× 18 0.3× 27 466
Lorne Houten United States 10 36 0.4× 86 1.1× 102 1.5× 51 0.8× 70 1.2× 19 564
Remy L. Yunker United States 12 65 0.8× 38 0.5× 154 2.2× 102 1.5× 17 0.3× 36 457
Kunio Sato Japan 10 151 1.8× 219 2.9× 193 2.8× 89 1.3× 87 1.5× 31 551
Janet C. Ludwig United States 13 83 1.0× 33 0.4× 149 2.2× 38 0.6× 18 0.3× 15 476
Takashi Naito Japan 14 35 0.4× 30 0.4× 222 3.2× 39 0.6× 52 0.9× 27 585
K. Mynett United Kingdom 13 79 0.9× 33 0.4× 357 5.2× 76 1.2× 33 0.6× 15 712
Siegfried Vogl Germany 8 50 0.6× 65 0.9× 122 1.8× 25 0.4× 68 1.2× 20 418

Countries citing papers authored by E Péquignot

Since Specialization
Citations

This map shows the geographic impact of E Péquignot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Péquignot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Péquignot more than expected).

Fields of papers citing papers by E Péquignot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Péquignot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Péquignot. The network helps show where E Péquignot may publish in the future.

Co-authorship network of co-authors of E Péquignot

This figure shows the co-authorship network connecting the top 25 collaborators of E Péquignot. A scholar is included among the top collaborators of E Péquignot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Péquignot. E Péquignot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Patel, Tarun B., et al.. (2007). Transgenic avian-derived recombinant human interferon-a2b (AVI-005) in healthy subjects: an open-label, single-dose, controlled study. International Journal of Clinical Pharmacology and Therapeutics. 45(3). 161–168. 6 indexed citations
3.
Sollars, Vincent E., E Péquignot, Jay L. Rothstein, & Arthur M. Buchberg. (2006). Analysis of expansion of myeloid progenitors in mice to identify leukemic susceptibility genes. Mammalian Genome. 17(8). 808–821. 4 indexed citations
4.
Marcellin, Patrick, E Péquignot, Elisabeth Delarocque‐Astagneau, et al.. (2006). 468 Evidence for high rates of HCV and HBV related mortality in FRANCE: A large-scale national survey. Journal of Hepatology. 44. S174–S174. 2 indexed citations
5.
Péquignot, E, et al.. (2005). Lack of effect of aprepitant on the pharmacokinetics of hydrodolasetron in CYP2D6 extensive and poor metabolizers. Clinical Pharmacology & Therapeutics. 77(2). P47–P47. 3 indexed citations
6.
Koratkar, Revati, et al.. (2004). Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis. Genomics. 84(5). 844–852. 12 indexed citations
7.
Wernicke, A. Gabriella, et al.. (2004). Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 60(5). 1357–1363. 58 indexed citations
8.
Veronese, Maria Luisa, Lisa Gillen, Joanne Burke, et al.. (2003). Exposure‐Dependent Inhibition of Intestinal and Hepatic CYP3A4 In Vivo by Grapefruit Juice. The Journal of Clinical Pharmacology. 43(8). 831–839. 112 indexed citations
9.
Koratkar, Revati, E Péquignot, Walter W. Hauck, & Linda D. Siracusa. (2002). The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus.. PubMed. 62(19). 5413–7. 13 indexed citations
10.
Almeida-Toledo, Lurdes Foresti de, et al.. (2001). XX:XY sex chromosome system with X heterochromatinization: an early stage of sex chromosome differentiation in the Neotropic electric eel <i>Eigenmannia virescens</i>. Cytogenetic and Genome Research. 95(1-2). 73–78. 48 indexed citations
11.
Schwartz, Allan B., et al.. (1992). RBC improved survival due to recombinant human erythropoietin explains effectiveness of less frequent, low dose subcutaneous therapy.. PubMed. 38(5). 283–9. 13 indexed citations
12.
Lemonnier, Daniel, et al.. (1975). Metabolism of the mouse made obese by a high-fat diet.. PubMed. 1(2). 77–85. 20 indexed citations
13.
Gasquet, P. de & E Péquignot. (1973). Changes in Adipose Tissue and Heart Lipoprotein Lipase Activities and in Serum Glucose, Insulin and Corticosterone Concentrations in Rats Adapted to a Daily Meal. Hormone and Metabolic Research. 5(6). 440–443. 37 indexed citations
14.
Gasquet, P. de, et al.. (1973). Adipose-tissue lipoprotein lipase activity and cellularity in the genetically obese Zucker rat (fa/fa) (Short Communication). Biochemical Journal. 132(3). 633–635. 21 indexed citations
15.
Gasquet, P. de & E Péquignot. (1972). Lipoprotein lipase activities in adipose tissues, heart and diaphragm of the genetically obese mouse(ob-ob). Biochemical Journal. 127(2). 445–447. 34 indexed citations
16.
Chartier, P., et al.. (1970). [Gastro-pleuro-broncho-cutaneous fistula].. PubMed. 96(12). 841–8. 1 indexed citations
17.
Péquignot, E, et al.. (1970). [Study of the digestion of 40 patients with resected small intestines].. PubMed. 1. 51–64. 1 indexed citations
18.
Péquignot, E, et al.. (1965). [Protein anabolism produced in man by a new steroid: methyltrienolone].. PubMed. 73(47). 2655–8. 1 indexed citations
19.
Péquignot, G, E Péquignot, & J Caroli. (1960). Effets toxiques retardés après traitement d’ascites cirrhotiques par la chlorothiazide. Chemotherapy. 1(4-5). 300–311. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiro Nishizumi Breakdown of academic impact, for papers by Ibrahim M. Yousef Breakdown of academic impact, for papers by Jin‐Ying Lu Breakdown of academic impact, for papers by Lorne Houten Breakdown of academic impact, for papers by Remy L. Yunker Breakdown of academic impact, for papers by Kunio Sato Breakdown of academic impact, for papers by Janet C. Ludwig Breakdown of academic impact, for papers by Takashi Naito Breakdown of academic impact, for papers by K. Mynett Breakdown of academic impact, for papers by Siegfried Vogl
Rankless by CCL
2026